| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $317K | — | -3.9% |
| Cost of Revenue | $262K | — | +48.9% |
| Gross Profit | $55K | — | -64.3% |
| R&D Expense | $1.3M | — | +27.6% |
| SG&A Expense | $1.2M | — | +117.7% |
| Operating Income | -$2.5M | — | -74.0% |
| Interest Expense | $1K | — | — |
| Pre-tax Income | -$2.4M | — | -100.5% |
| Income Tax | $0 | — | — |
| Net Income | -$2.4M | — | -100.5% |
| EPS (Basic) | -$0.02 | — | +0.0% |
| EPS (Diluted) | -$0.02 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $207K | -77.0% | -48.9% |
| Short-term Investments | $28K | -26.3% | — |
| Accounts Receivable | $37K | +208.3% | +8.8% |
| Inventory | $638K | -0.3% | -53.1% |
| Current Assets | $1.1M | -35.9% | -60.4% |
| Total Assets | $9.2M | -5.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.2M | — | -67.5% |
| Capital Expenditures | $1K | — | -94.4% |
| Investing Cash Flow | -$170K | — | -19.7% |
| Financing Cash Flow | $710K | — | -11.8% |
| Free Cash Flow | -$1.2M | — | -63.6% |
| +5.0% |
| Current Liabilities | $2.9M | +33.3% | +27.3% |
| Total Liabilities | $3.1M | +33.9% | +26.8% |
| Stockholders' Equity | $6.1M | -17.5% | -3.3% |